Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.

COVID-19 may harm male fertility and damage the reproductive system.

Panax ginseng extract may help prevent hair loss caused by DKK-1.

The document concludes that the human keratin gene cluster is complex, with a need for updated naming to reflect over 50 functional genes important for hair and skin biology.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

KGF-1 135 is a stable and effective alternative for treating oral mucositis.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

PCOS is linked to low-grade chronic inflammation.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

The Spanish Hair-Specific Skindex-29 questionnaire effectively measures the quality of life impact of hair loss in Spanish-speaking women.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

EH-MSCs may help treat hair loss by reducing inflammation.

Blocking IL-17a can improve age-related smell loss in mice.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Glypicans help hair follicle stem cells differentiate by interacting with specific receptors, influencing hair growth.

Removing SIX1 in fat cells reduces skin fibrosis.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Low-level laser therapy may help stem cells grow and function better, aiding in healing and tissue repair.

Advancements in biomaterials and nanotechnology are improving medical applications like hair growth, bone regeneration, and cancer treatment.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.